Champions Oncology (CSBR) EBT (2010 - 2026)
Champions Oncology (CSBR) recorded quarterly EBT of -$237000.0 in Q1 2026, down 192.94% quarter-over-quarter from $255000.0 in Q4 2025, and down 105.25% on a YoY basis from $4.5 million in Q1 2025.
Champions Oncology (CSBR) EBT (2010 - 2026) Analysis & Trends
Champions Oncology's EBT history runs 17 years deep, the most recent figure standing at -$237000.0 for Q1 2026.
- In Q1 2026, EBT fell 105.25% year-over-year to -$237000.0; the TTM figure through Jan 2026 stood at -$2.4 million (down 137.46% YoY), while the FY2025 annual figure was $4.6 million, up 163.3% from the prior year.
- EBT was -$237000.0 for Q1 2026 at Champions Oncology, down from $255000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of $4.5 million in Q1 2025 to a low of -$2.5 million in Q2 2023.
- Historically, EBT has averaged -$466411.8 across 5 years, with a median of -$302000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: EBT tumbled 102900.0% in 2023, then surged 279.36% in 2025.
- A 5-year view of EBT shows it stood at -$2000.0 in 2022, then sank by 102900.0% to -$2.1 million in 2023, then soared by 135.87% to $739000.0 in 2024, then sank by 65.49% to $255000.0 in 2025, then tumbled by 192.94% to -$237000.0 in 2026.
- The last three EBT figures came in at -$237000.0 (Q1 2026), $255000.0 (Q4 2025), and -$452000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.48 Mn |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn | -237,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -237,000.00 |
| Oct 31, 2025 | 255,000.00 |
| Jul 31, 2025 | -452,000.00 |
| Apr 30, 2025 | -1.96 Mn |
| Jan 31, 2025 | 4.52 Mn |
| Oct 31, 2024 | 739,000.00 |
| Jul 31, 2024 | 1.33 Mn |
| Apr 30, 2024 | -190,000.00 |
| Jan 31, 2024 | -2.52 Mn |
| Oct 31, 2023 | -2.06 Mn |
| Jul 31, 2023 | -2.54 Mn |
| Apr 30, 2023 | -2.54 Mn |
| Jan 31, 2023 | -2.42 Mn |
| Oct 31, 2022 | -2,000.00 |
| Jul 31, 2022 | -302,000.00 |
| Apr 30, 2022 | -346,000.00 |
| Jan 31, 2022 | 798,000.00 |
| Oct 31, 2021 | 289,000.00 |
| Jul 31, 2021 | -158,000.00 |
| Apr 30, 2021 | -641,000.00 |